abstract |
The present invention provides an anti-cancer agent containing 1,2-dipalmitoleoyl-sn-glycero-3-phosphoethanolamine as an active ingredient, an agent to induce cell death, a protein phosphatase 2A activation potentiator, and a protein tyrosine phosphatase 1B activation potentiator, and the like. |